A pan-cancer analysis of Dyskeratosis congenita 1 (DKC1) as a prognostic biomarker
Abstract Background Dyskeratosis congenita 1 (DKC1), a critical component of telomerase complex, is highly expressed in a variety of human cancers. However, the association of DKC1 with cancer occurrence and development stages is not clear, making a pan-cancer analysis crucial. Methods We conducted...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Hereditas |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41065-023-00302-y |